SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Reports about Jensen Huangs alleged relationshipsincluding one involving a suspected Chinese intelligence assetand speculation about his future as CEO are driving debate over Nvidias leadership, governance, and potential national-security or export-control fallout. Traders are divided between fearing further uncertainty and viewing the selloff as an overreaction given Nvidias AI-chip business; Huangs possible departure remains unconfirmed.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

CoreWeaves strong results lifted AI-neocloud shares and fueled a rally in Nebius ahead of its Q3 report. Traders are split between expecting strong growth and guidance and worrying that the run-up has priced in good news, with heavy investment and financing needs adding to the debate; Nvidia-related uncertainty also contributed to volatility.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is drawing attention around its Q3 earnings report, with traders focused on whether revenue growth, margins, cash burn and guidance validate its expansion in autonomous defense systems. Bulls see heavy short interest as potential fuel for a squeeze if results and outlook are strong, while bears point to losses, dilution and the risk of a post-report selloff.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

A sharp rebound in memory and AI-linked sharesattributed by traders to CoreWeaves upbeat outlook renewing confidence in AI infrastructure spending and Evercores bullish view of NAND demandhas drawn attention to SNDK. Bulls welcome the move and speculate about short covering, while others warn of volatility and debate the unconfirmed Jensen Huang ouster report as a sector overhang.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is under pressure as traders react to alleged links between the company and Megaspeed, which is tied to the Nvidia CEO spy controversy; the allegations have raised fears of tighter U.S. chip-export controls and risks to Alibabas AI and cloud ambitions. Some traders question the evidence or argue Alibabas own T-Head chips could benefit, while bearish sentiment focuses on the possible impact of restricted access to Nvidia hardware.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Reports that Nvidias board is weighing Jensen Huangs future have fueled a rotation into AMD, with traders betting Nvidias leadership turmoil could benefit rival chipmakers. Others argue the headlines do not change AMDs competitive position and question whether the rally is sustainable.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgents preliminary update that fiscal Q1 revenue and adjusted EBITDA will exceed the high end of guidance, alongside clarification that the CFOs departure was not related to a company disagreement, has fueled attention after a sharp selloff. Traders are split between calling the decline an overreaction and buying the dip, and remaining concerned about the leadership change, managements communication, and whether confidence will recover.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX automotive-software business is the main bullish focus, with traders pointing to design wins, partner integrations and a growing royalty backlog while speculating about an Alloy Kore update. Some also see BB benefiting from money rotating away from Nvidia amid CEO-related uncertainty, but the community is divided over whether the strength can break the stock out of its prolonged trading range.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is drawing attention ahead of the FDAs Nov. 22 decision on deramiocel for Duchenne muscular dystrophy, with managements confidence and comments about potential labeling, alongside an analyst upgrade, adding to optimism. Many traders are bullish and speculate about short covering, while others stress that approval is uncertain after the advisory committees negative vote on the earlier cardiomyopathy-focused case.

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded on November 9, 2020 and is headquartered in Boston, MA.

PepGen Inc

PepGens sharp move followed positive Phase 2 data for its myotonic dystrophy program, while a large equity offering has shifted much of the discussion to potential dilution. Traders are divided between those focused on the clinical results and continued buying, and those expecting selling pressure from the added shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harrow (HROW) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Harrow (HROW) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Harrow (HROW) Q3 Earnings Lag Estimates

Harrow (HROW) delivered earnings and revenue surprises of -7.69% and +0.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical (PROF) Reports Q3 Loss, Beats Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of -10.53% and +0.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Prelude Therapeutics Incorporated (PRLD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Prelude Therapeutics (PRLD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Harrow (HROW) Expected to Beat Earnings Estimates: Should You Buy?

Harrow (HROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PHIL Partners with Harrow to Power HarrowRx, One Prescribing Destination for Harrows Eye Care Portfolio

PHIL Inc., the technology-powered patient access platform, today announced its partnership with Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, to launch HarrowRx, Harrows new prescribing and access platform. HarrowRx gives eye care providers...

Do Options Traders Know Something About Harrow Stock We Don't?

Investors need to pay close attention to HROW stock based on the movements in the options market lately.

Harrow's Iheezo Cuts Eye-Injection Discomfort by More Than Half

Harrow (NASDAQ: HROW) posts positive study results for IHEEZO ophthalmic gel, significantly reducing IVT injection patient discomfort.read more...

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +19.23% and -5.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$HROW Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.25 down -24.24% YoY
• Reported revenue of $99.3M up 38.61% YoY
• Harrow reaffirmed full-year 2026 revenue guidance of $350M to $365M and updated full-year 2026 Adjusted EBITDA guidance to more than $40M, including fourth-quarter Adjusted EBITDA of more than $33M.

Stocktwits

Harrow Health Inc

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.25 down -24.24% YoY
• Reported revenue of $99.3M up 38.61% YoY
• Harrow reaffirmed full-year 2026 revenue guidance of $350M to $365M and updated full-year 2026 Adjusted EBITDA guidance to more than $40M, including fourth-quarter Adjusted EBITDA of more than $33M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside

Equity

Extremely Bullish Sentiment

Harrow (HROW) announced on Friday that it has entered into an agreement to acquire privately held Melt Pharmaceuticals for an undisclosed price.While Harrow is a provider of ophthalmic disease management solutions, Melt Pharmaceuticals is focused on developing non-opioid therapies for sedation during medical procedures. Melt was spun out of Harrow in January 2019.The acquisition will <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.harrow.com/news-releases/news-release-details/harrow-acquire-melt-pharmaceuticals">include</a> Melt’s lead investigational therapy, MELT-300, a sublingually delivered formulation of a fixed dose of Midazolam (3mg) and Ketamine (50mg) designed to provide rapid, predictable sedation and analgesia without the need for intravenous administration.Shares of Harrow jumped 4% at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HROW">HROW stock</a> stayed within ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.MELT-300 was found to be statistically superior to both sublingual Midazolam alone and placebo in providing successful procedural sedation in a late-stage study. A recently completed cardiac safety study also indicated that MELT-300 did not alter normal heart rhythm, supporting the therapy’s safety profile. Harrow now plans to submit a new drug application to the U.S. Food and Drug Administration for the sedative in 2027, and is eyeing a commercial launch in the U.S. in 2028.If the FDA approves MELT-300, the company intends to discontinue the MKO Melt sedation product, marketed through its ImprimisRx subsidiary, for cataract surgeries. The company also sees potential for MELT-300 to be used in other procedures, including claustrophobia during MRIs, sedation for colonoscopies, dental procedures, gastroenterology procedures, and other interventions.The closing of the merger transaction, however, is subject to customary closing conditions, including approval by Melt shareholders, Harrow added.HROW stock is up 43% this year and by about 9% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/costco-draws-mixed-reactions-from-wall-street-despite-q4-beat-here-is-why/chDVjZGR3eX">Costco Draws Mixed Reactions From Wall Street Despite Q4 Beat: Here’s Why</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

The acquisition will include Melt’s lead investigational therapy, MELT-300, designed to provide rapid, predictable sedation and analgesia without the need for intravenous administration. 

BlackRock Institutional Trust Company N.A. - iShares Russell 3000 ETF

Vanguard Russell 2000 Growth ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$29.37
Prev Close	$30.36
Open	$29.88
Dividend Yield	0.00%
50-Day Moving Average	$31.15
Beta	1.46
Avg. Volume	591,948.70
PE Ratio	-38.01

52-Week High	$54.85
52-Week Low	$25.76
Market Capitalization	$1.14B
EPS (Annual)	-$0.1398
Price to Book	37.76
Revenue Per Employee	$730,034.85

Feed

News

Sentiment

Earnings

Fundamentals

Info

HROW Fundamentals